Stock listing

OTC:SRIMF StemRIM Inc. Stock

US listing (OTC) of StemRIM Inc. · home listing Tokyo:4599

Follow StemRIM Inc. into a list and get an email when it puts out news.

StemRIM Inc. logo
Ticker
OTC:SRIMF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Latest news

Notice Regarding US Patent Registration of SR-GT1 for Dystrophic Epidermolysis Bullosa

Oct 7, 2026

Patent Registration in South Korea for Redasemtide in Cartilage Disorders

Sep 25, 2026

StemRIM Announces Fixed Details of the Issuance of Stock Options to Employees

Sep 10, 2026

StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to Employees

Sep 9, 2026

StemRIM Announces Patent Registration for SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in South Korea

Aug 3, 2026

StemRIM Announces Patent Registration (Mexico) for Redasemtide, as an Additional Therapeutic Indication of Cartilage Disorders

Jul 22, 2026

StemRIM Announces Patent Registration (Canada) for Redasemtide, as an Additional Therapeutic Indication for Cardiomyopathy, Old Myocardial Infarction

Jul 13, 2026

StemRIM Announces Patent Registration for Stem Cell Gene Therapy Technology (SR-GT1) Aimed at Curative Treatment of DEB in,South Korea

Jul 8, 2026

[Delayed]Notice Regarding Recognition of Non-operating Income (Subsidy Income)

Jun 18, 2026

StemRIM Announces Patent Registration (Australia) for Redasemtide, as an Additional Therapeutic Indication of Cartilage Disorders

Jun 17, 2026

All StemRIM Inc. news

Decks

StemRIM Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
12 in the last 12 months · 12 in all · newest Oct 7, 2026 · oldest 2026
Decks
5 decks · latest Sep 11, 2026

Where StemRIM Inc. is listed

ListingExchangeCountryCurrency
Tokyo:4599 ステムリム · Home listingTokyoJapanJPY
OTC:SRIMF · This pageOTCUnited StatesUSD

Log in to ask 6ix AI your own questions about StemRIM Inc.